The efficacy and safety of antibodies targeting PD-1 for treatment in advanced esophageal cancer: A systematic review and meta-analysis

BACKGROUND: A novel therapy based on programmed death 1 (PD-1) inhibitors has been proved to be effective in advanced esophageal cancer. This article is a meta-analysis that aims to compare the efficacy and safety of anti-PD-1 therapy with chemotherapy in esophageal cancer. PATIENTS AND METHODS: Dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yao, Guan, Lulu, Xu, Mengli, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042180/
https://www.ncbi.nlm.nih.gov/pubmed/33784583
http://dx.doi.org/10.1016/j.tranon.2021.101083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042180/
https://www.ncbi.nlm.nih.gov/pubmed/33784583
http://dx.doi.org/10.1016/j.tranon.2021.101083

Ejemplares similares